Pongsak Sapakdee/iStock via Getty Images Market review US equities finished higher for 4Q25 amid the longest government shutdown in history. The Fund's benchmark, the Russell 2000® Value Index, advanced 3.26%. Small-cap growth equities lagged small-cap value equities during the quarter as the Russell 2000® Growth Index gained 1.22%. The large-cap S&P 500® Index advanced 2.66%, trailing small-cap v...
Pongsak Sapakdee/iStock via Getty Images Market review US equities finished higher for 4Q25 amid the longest government shutdown in history. The Fund's benchmark, the Russell 2000® Value Index, advanced 3.26%. Small-cap growth equities lagged small-cap value equities during the quarter as the Russell 2000® Growth Index gained 1.22%. The large-cap S&P 500® Index advanced 2.66%, trailing small-cap value equities for the second consecutive quarter. Sector performance within the Russell 2000 Value Index was mixed in the period as 6 of 11 sectors advanced. Within the benchmark, lower-quality stocks, those companies with a lower return on equity ('ROE'), gained more than those with higher ROEs and companies without earnings outperformed companies with earnings. The healthcare, materials, transportation, energy, and financial services sectors in the benchmark outperformed. The technology, consumer staples, and industrials sectors declined during the quarter. The Federal Open Market Committee ('FOMC') cut rates by 25 basis points (a basis point is one hundredth of a percentage point) at both its November and December meetings, with the market expecting further cuts in 2026. The government shutdown, which spanned from October 1 to November 12, disrupted federal government data releases. The US unemployment rate, at 4.4% in December, showed little change over the quarter. Inflation continued to decline though it remained above 2% in November. Consumers' year-ahead inflation expectations have also decreased (Source: University of Michigan). Within the Fund For 4Q25, Nomura Small Cap Value Fund Institutional class shares slightly lagged the return of its benchmark, the Russell 2000 Value Index. Stock selection and an underweight allocation to the healthcare sector were the most notable detractors from the Fund's performance for the quarter. The Fund does not hold companies in the biotechnology or pharmaceuticals industries as they don't meet our investment discipline. However, ...
(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter of $27.49 million or $1.18 per share, compared to a net loss of $10.68 million or $0.55 per share in the prior-year quart
(RTTNews) - Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter of $27.49 million or $1.18 per share, compared to a net loss of $10.68 million or $0.55 per share in the prior-year quart
ACCO Brands ( ACCO ) declares $0.075/share quarterly dividend , in line with previous. Forward yield 7.28% Payable March 26; for shareholders of record March 20; ex-div March 20. See ACCO Dividend Scorecard, Yield Chart, & Dividend Growth. More on ACCO Brands Small-cap stocks with highest dividend yield grade ACCO Brands to acquire EPOS for $11.7M Seeking Alpha’s Quant Rating on ACCO Brands Histor...
ACCO Brands ( ACCO ) declares $0.075/share quarterly dividend , in line with previous. Forward yield 7.28% Payable March 26; for shareholders of record March 20; ex-div March 20. See ACCO Dividend Scorecard, Yield Chart, & Dividend Growth. More on ACCO Brands Small-cap stocks with highest dividend yield grade ACCO Brands to acquire EPOS for $11.7M Seeking Alpha’s Quant Rating on ACCO Brands Historical earnings data for ACCO Brands Dividend scorecard for ACCO Brands
FRMO press release ( FRMO ): Q2 GAAP EPS of -$0.30. Revenue of $0.86M (-2.3% Y/Y). More on FRMO Seeking Alpha’s Quant Rating on FRMO Financial information for FRMO
FRMO press release ( FRMO ): Q2 GAAP EPS of -$0.30. Revenue of $0.86M (-2.3% Y/Y). More on FRMO Seeking Alpha’s Quant Rating on FRMO Financial information for FRMO
AI ToC战火不断。 距离夸克AI眼镜正式发售仅三个月，2月27日，阿里又宣布旗下个人AI助手“千问”正式进军AI硬件领域，今年将面向全球市场推出多款不同形态的AI硬件产品。 记者了解到，千问将在西班牙巴塞罗那举行的2026年世界移动通信大会（MWC）上发布首款同名AI眼镜，并于3月2日开启线上线下全渠道预约。此外，阿里内部人士透露，除AI眼镜之外，千问还会在年内陆续发布AI指环、AI耳机等产品...
Stephen Auth, CIO, equity at Federated Hermes, explains the factors behind his firm’s decision to trim their 2026 target for the S&P 500 to 7,500. (Source: Bloomberg)
Stephen Auth, CIO, equity at Federated Hermes, explains the factors behind his firm’s decision to trim their 2026 target for the S&P 500 to 7,500. (Source: Bloomberg)
Anteris Technologies Global Corp. press release ( AVR ): FY company’s net operating cash outflows for the year ended December 31, 2025, were $77.8 million, in line with the increase in clinical, regulatory and manufacturing requirements to support the PARADIGM Trial. More on Anteris Technologies Global Corp. Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic pla...
Anteris Technologies Global Corp. press release ( AVR ): FY company’s net operating cash outflows for the year ended December 31, 2025, were $77.8 million, in line with the increase in clinical, regulatory and manufacturing requirements to support the PARADIGM Trial. More on Anteris Technologies Global Corp. Anteris Technologies Global prices $200M public offering and concurrent $90M Medtronic placement Seeking Alpha’s Quant Rating on Anteris Technologies Global Corp. Historical earnings data for Anteris Technologies Global Corp. Financial information for Anteris Technologies Global Corp.
Restoring Britain Authored by Laura Hollis via The Epoch Times, There’s a revolution brewing across the Big Pond. The British people were already fed up with the Labour government headed by Prime Minister Keir Starmer. And then the man Starmer appointed to be ambassador to the United States—Peter Mandelson—was exposed as having a deep friendship with sex predator Jeffrey Epstein, even after Epstei...
Restoring Britain Authored by Laura Hollis via The Epoch Times, There’s a revolution brewing across the Big Pond. The British people were already fed up with the Labour government headed by Prime Minister Keir Starmer. And then the man Starmer appointed to be ambassador to the United States—Peter Mandelson—was exposed as having a deep friendship with sex predator Jeffrey Epstein, even after Epstein was convicted on charges of sex with a minor in 2008. Mandelson is now under investigation for possibly passing sensitive government information to Epstein. Starmer is viewed as being crippled by these revelations and losing support within his own party. But it’s the split on the political Right that is most interesting at the moment. For quite some time, Nigel Farage’s Reform UK Party has been the favorite to unseat Labour in the next general parliamentary election in 2029. Farage came into the international spotlight as the leader of the movement to take Britain out of the European Union (“Brexit”). But Farage is increasingly viewed as having become “establishment,” particularly on the question of what to do about the millions of Muslim migrants who have poured into England and the rest of the United Kingdom. Farage and former fellow Reform UK MP Rupert Lowe had a serious falling-out last year. Lowe was—and is—pushing for mass deportations, a policy that Farage has dismissed as “beyond the point of reasonableness, of decency, of morality.” Lowe publicly criticized Farage’s leadership of Reform UK; Farage responded by kicking Lowe out of the party, accusing him of “bullying” staff members and of making threats against party chairman Zia Yusef. It would further appear that Farage was responsible for a police raid on Lowe’s home to confiscate his firearms. (No charges were filed against Lowe, and his guns were returned to him.) Lowe has returned with a vengeance. Two weeks ago, he announced the formation of a new political party, “Restore Britain.” “Restore,” as it is now ...
National Healthcare press release ( NHC ): FY GAAP EPS of $1.58. Revenue of $386.5M (+4.6% Y/Y). More on National Healthcare National HealthCare: 50% Return In The Past 6 Months And Still Undervalued Seeking Alpha’s Quant Rating on National Healthcare Dividend scorecard for National Healthcare Financial information for National Healthcare
National Healthcare press release ( NHC ): FY GAAP EPS of $1.58. Revenue of $386.5M (+4.6% Y/Y). More on National Healthcare National HealthCare: 50% Return In The Past 6 Months And Still Undervalued Seeking Alpha’s Quant Rating on National Healthcare Dividend scorecard for National Healthcare Financial information for National Healthcare
Emin reminds us of the deep power of art, Ramses II parades his megalomaniac gold and Rose Wylie’s witty paintings finally get their due – all in your weekly dispatch Tracey Emin: A Second Life The most serious and intelligent, as well as passionate, artist of her generation proves art can still touch us all and express what it is to be alive. • Tate Modern, London , until 31 August Continue readi...
Emin reminds us of the deep power of art, Ramses II parades his megalomaniac gold and Rose Wylie’s witty paintings finally get their due – all in your weekly dispatch Tracey Emin: A Second Life The most serious and intelligent, as well as passionate, artist of her generation proves art can still touch us all and express what it is to be alive. • Tate Modern, London , until 31 August Continue reading...
A lot of people assume that they can't make changes to their Medicare coverage until the program's fall open enrollment period rolls around in October. But if you're enrolled in a Medicare Advantage plan , the rules are a bit different. Medicare Advantage has its own open enrollment period that runs from Jan. 1 through March 31 each year. If you have one of these plans and aren't so thrilled with ...
A lot of people assume that they can't make changes to their Medicare coverage until the program's fall open enrollment period rolls around in October. But if you're enrolled in a Medicare Advantage plan , the rules are a bit different. Medicare Advantage has its own open enrollment period that runs from Jan. 1 through March 31 each year. If you have one of these plans and aren't so thrilled with it, you have about another month to make a switch. Here are some quick tips for choosing replacement coverage. Image source: Getty Images. Continue reading